Nā huahana

  • Biopharmaceutical |Na ma'i puuwai |2-Chloro-L-phenylalanine |CAS No.185030-83-5

    Biopharmaceutical |Na ma'i puuwai |2-Chloro-L-phenylalanine |CAS No.185030-83-5

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Na ma'i puuwai |Ke Koko Kiekie |2-CHLORO-L-PHENYLALANINE |CAS:185030-83-5 |C9H10ClNO2

  • 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 330786-24-8

    3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 330786-24-8

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |ʻOihana Laʻau |Nā lāʻau antitumor |Ibrutinib Intermediates |3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |CAS:330786-24-8 |C17H13N5O

  • 3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole 330792-70-6

    3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole 330792-70-6

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |ʻOihana Laʻau |Nā lāʻau antitumor |Ibrutinib Intermediates |3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole |CAS: 330792-70-6|C16H12N4O

  • 1,4-Bis(4-aminophenoxy)benzene 3491-12-1

    1,4-Bis(4-aminophenoxy)benzene 3491-12-1

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Kemimi mea waiwai |Polyimide monomers |1,4-Bis(4-aminophenoxy)benzene |CAS:3491-12-1 |C18H16N2O2

     

  • Itopride hydrochloride 122892-31-3

    Itopride hydrochloride 122892-31-3

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |API no na hana |ʻO nā lāʻau lapaʻau ʻōnaehana |Itopride hydrochloride a me kona mau mea waena |Itopride hydrochloride |CAS:122892-31-3 |C20H26N2O4.HCl

  • Benazepril hydrochloride 86541-74-4

    Benazepril hydrochloride 86541-74-4

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Na ma'i puuwai |Ke Koko Kiekie |Benazepril hydrochloride |CAS:86541-74-4|C24H28N2O5.HCl

  • 1-Boc-3-hydroxypiperidine 85275-45-2

    1-Boc-3-hydroxypiperidine 85275-45-2

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |ʻOihana Laʻau |Nā lāʻau antitumor |Ibrutinib Intermediates |1-Boc-3-hydroxypiperidine |CAS:85275-45-2 |C10H19NO3

  • L-Leucine benzyl ester p-toluenesulfonate paʻakai 1738-77-8

    L-Leucine benzyl ester p-toluenesulfonate paʻakai 1738-77-8

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |L-Leucine benzyl ester p-toluenesulfonate paʻakai |CAS:1738-77-8 |C13H19NO2.C7H8O3S

     

  • Boc-D-Serine 6368-20-3

    Boc-D-Serine 6368-20-3

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |'Amino acid series Natural Amino Acid |Boc-D-Serine |CAS:6368-20-3|C8H15NO5

  • D-Serine 312-84-5

    D-Serine 312-84-5

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |moʻo ʻakika amino |D-Serine |CAS:312-84-5 |C3H7NO3

  • Boc-D-3-Bromophenylalanine 261360-77-4

    Boc-D-3-Bromophenylalanine 261360-77-4

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |moʻo ʻakika amino |Boc-D-3-Bromophenylalanine |CAS:261360-77-4 |C14H18BrNO4

  • Boc-L-aspartic acid 13726-67-5

    Boc-L-aspartic acid 13726-67-5

    ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |moʻo ʻakika amino |Boc-L-aspartic acid |CAS:13726-67-5 |C9H15NO6